• COVID-19
  • Simoa® Technology
  • Therapeutic Areas
    NeurologyOncologyImmunology/InflammationInfectious DiseaseCardiology
  • Products & Services
    Simoa® Assay KitsReady-to-use Simoa® assay kits compatible with Quanterix instrumentsSimoa® NfL LDTSimoa® p-Tau 181 LDTHD-X™ Automated Immunoassay AnalyzerOur flagship automated immunoassay analyzer offering ultrasensitive biomarker measurementSR-X™ Biomarker Detection SystemBenchtop digital immunoassay platform delivering ultrasensitive biomarker detection in a compact instrumentSP-X Imaging and Analysis System™Robust circulating biomarker detection in a benchtop multiplex immunoassay platformSimoa® Accelerator LaboratoryFull-service center for biomarker testing services and custom immunoassay developmentUman NF-Light™NfL ELISA kits and antibodies for the detection of neurofilament light chainHomebrew – Custom Assay DevelopmentUltrasensitive immunoassay development solution providing flexibility for specialized research applications
  • Support & Resources
    Customer Care & Technical SupportSafety Data Sheets & Cert. of AnalysisProduct BrochuresWhitepapers & App NotesPublications And PostersConferencesWebinars
  • Media Center
    Press ReleasesVideos & RecordingsIn The NewsBlog
  • Company
    Meet the Management Team
  • Contact Us
  • Careers
  • Investors
  • Customer Portal
  • Search

stay tuned

Subscribe to our newsletter


    info@quanterix.com

    617 301 9400

    900 Middlesex TPKE
    Billerica, MA 01821
    USA

    • Investor Portal
    • Customer Portal
    • Contact Us
    • Financial Conflict of Interest Policy
    • Terms and Conditions
    • Privacy Shield Statement
    © 2023 Quanterix All rights reserved.
    • Privacy Policy

    This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

    AgreeLearn more